Fig. 2From: Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysisForest plot reflects the association between TKIs-induced hypertension and oncologic outcomes (overall survival) in different TKIs subgroups (1: axitinib; 2: sorafenib; 3: sunitinib; 4: pazopanib)Back to article page